SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-209067
Filing Date
2022-08-02
Accepted
2022-08-01 18:48:01
Documents
14
Period of Report
2022-08-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d346007d8k.htm   iXBRL 8-K 31481
2 EX-99.1 d346007dex991.htm EX-99.1 8149
6 GRAPHIC g346007g0801211910312.jpg GRAPHIC 3587
  Complete submission text file 0001193125-22-209067.txt   169022

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyme-20220801.xsd EX-101.SCH 2527
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20220801_lab.xml EX-101.LAB 18034
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20220801_pre.xml EX-101.PRE 11320
8 EXTRACTED XBRL INSTANCE DOCUMENT d346007d8k_htm.xml XML 3598
Mailing Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4
Business Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 221126297
SIC: 2834 Pharmaceutical Preparations